ABRO1 arrests cardiomyocyte proliferation and myocardial repair by suppressing PSPH

Tao Wang1, Lu-Yu Zhou2, Xin-Min Li2

  • 1Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao 266021, China; Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan 250014, China.

Insights

Abraxas 2 (ABRO1) regulates cardiomyocyte proliferation and cardiac repair by influencing METTL3-mediated m6A methylation. Its deletion promotes heart regeneration, while its overexpression inhibits it.

Area of Science:

  • Cardiovascular Biology
  • Molecular and Cellular Cardiology
  • Epigenetics

Background:

  • The role of Abraxas 2 (ABRO1) in cardiomyocyte proliferation and myocardial regeneration remains unclear.
  • ABRO1 is a component of the lysine63-linked deubiquitinating system.

Purpose of the Study:

  • To investigate the function of ABRO1 in cardiomyocyte proliferation and cardiac regeneration.
  • To elucidate the molecular mechanism by which ABRO1 regulates these processes.

Main Methods:

  • Investigated ABRO1's role in mouse models with ABRO1 deletion or overexpression.
  • Analyzed cardiomyocyte proliferation, cardiac function after myocardial injury, and molecular pathways involving METTL3, m6A methylation, Psph mRNA, and CDK2 phosphorylation.

Main Results:

  • ABRO1 deletion enhanced cardiomyocyte proliferation and restored heart function post-injury.
  • ABRO1 overexpression inhibited neonatal cardiomyocyte proliferation and cardiac regeneration.
  • ABRO1 regulates cardiomyocyte proliferation via METTL3-mediated Psph mRNA methylation and subsequent CDK2 phosphorylation, controlling cell cycle progression.

Conclusions:

  • ABRO1 is crucial for cell cycle withdrawal and reduced proliferation in postnatal cardiomyocytes.
  • ABRO1 acts as a negative regulator of cardiac regeneration.
  • ABRO1 represents a potential therapeutic target for enhancing cardiomyocyte proliferation and cardiac repair in adult hearts.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
27
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
30
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
17
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
19
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K